Phreesia/$PHR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Phreesia
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Ticker
$PHR
Sector
Primary listing
NYSE
Employees
2,082
Headquarters
Website
Phreesia Metrics
BasicAdvanced
$1.4B
-
-$0.42
0.68
-
Price and volume
Market cap
$1.4B
Beta
0.68
52-week high
$32.76
52-week low
$17.07
Average daily volume
617K
Financial strength
Current ratio
2.118
Quick ratio
1.666
Long term debt to equity
1.596
Total debt to equity
4.293
Interest coverage (TTM)
-9.05%
Profitability
EBITDA (TTM)
-3.274
Gross margin (TTM)
68.02%
Net profit margin (TTM)
-5.35%
Operating margin (TTM)
-4.73%
Effective tax rate (TTM)
-4.22%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
-3.45%
Return on equity (TTM)
-8.76%
Valuation
Price to revenue (TTM)
2.966
Price to book
4.56
Price to tangible book (TTM)
9.58
Price to free cash flow (TTM)
47.817
Free cash flow yield (TTM)
2.09%
Free cash flow per share (TTM)
0.475
Growth
Revenue change (TTM)
15.31%
Earnings per share change (TTM)
-76.65%
3-year revenue growth (CAGR)
22.41%
3-year earnings per share growth (CAGR)
-50.79%
What the Analysts think about Phreesia
Analyst ratings (Buy, Hold, Sell) for Phreesia stock.
Bulls say / Bears say
In Q1 FY 2026, Phreesia generated $14.9 million in net operating cash flow and $7.5 million in free cash flow, reversing last year’s cash burn and strengthening its financial flexibility.
Phreesia’s adjusted EBITDA jumped to $20.8 million in Q1 FY 2026 from $4.1 million a year earlier, demonstrating significant progress toward higher margins and sustainable profitability.
On March 18, 2025, Jefferies raised its price target for Phreesia to $32 from $28 and reiterated its Buy rating, citing robust 17.8% revenue growth (last twelve months) and a strong 67.9% gross profit margin.
Citi cut its price target to $33 from $35 on May 28, 2025 and pointed out a 5% sequential decline in Phreesia’s Network Solutions segment, signaling volatility in a key growth area.
Despite operational gains, Phreesia posted a GAAP net loss of $3.9 million in Q1 FY 2026, showing the company is still not profitable under GAAP standards.
Phreesia’s stock remains in consolidation below its $30.53 buy point and has a Relative Strength Rating of 73, indicating its technical performance is lagging compared to leading peers.
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2025.
Phreesia Financial Performance
Revenues and expenses
Phreesia Earnings Performance
Company profitability
Phreesia News
AllArticlesVideos
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling
Business Wire4 weeks ago
Phreesia Named to TIME's 2025 List of the World's Top HealthTech Companies
Business Wire1 month ago
Becker's Names Phreesia's Sara DiNardo as one of 2025's Rising Stars of Healthcare
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Phreesia stock?
Phreesia (PHR) has a market cap of $1.4B as of November 04, 2025.
What is the P/E ratio for Phreesia stock?
The price to earnings (P/E) ratio for Phreesia (PHR) stock is 0 as of November 04, 2025.
Does Phreesia stock pay dividends?
No, Phreesia (PHR) stock does not pay dividends to its shareholders as of November 04, 2025.
When is the next Phreesia dividend payment date?
Phreesia (PHR) stock does not pay dividends to its shareholders.
What is the beta indicator for Phreesia?
Phreesia (PHR) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.